At a pediatric clinic in suburban Ohio, a new mother watches the nurse gently place her 2-week-old on the scale. The nurse records the weight, charts the percentile, and asks about feeding and sleep. The mother’s own blood pressure—which had been elevated at discharge—goes unmeasured. She mentions a persistent headache; the nurse nods sympathetically and returns to the baby’s chart. This scene, repeated thousands of times daily across the United States, encapsulates a systemic blind spot: the infant is weighed, but the mother is not.

The Infant Is Weighed, the Mother Is Not

Well-baby visits are a cornerstone of US pediatric care, with most infants attending at least five in the first year. The American Academy of Pediatrics recommends these visits include growth monitoring, developmental screening, and immunizations. What they do not include, in any standard protocol, is a maternal blood pressure check. This omission matters because cardiovascular causes account for roughly one in five pregnancy-related deaths in the US, and postpartum hypertension is a leading contributor.

Postpartum hypertension can arise de novo or as a continuation of preeclampsia, and it often peaks between three and seven days after delivery—well before the standard six-week obstetric visit. A 2022 study in Obstetrics & Gynecology found that nearly 12% of women develop hypertension in the first six weeks postpartum, and half of eclampsia cases occur after hospital discharge. Yet blood pressure screening is not consistently reimbursed outside of obstetric visits, and many women never attend that single check.

“They asked about the baby, not me,” said one mother interviewed for a 2024 survey by the National Birth Equity Collaborative. Her experience is typical: a 2023 analysis of commercial claims data found that fewer than 40% of women had a blood pressure measurement recorded between discharge and the six-week visit. The result is a system that meticulously tracks infant growth while leaving maternal health to chance.

A Policy Gap That Persists After Delivery

Medicaid covers roughly 42% of US births and provides 60 days of postpartum coverage under the American Rescue Plan Act’s state option. However, this coverage often excludes non-obstetric visits, and many plans do not reimburse for blood pressure checks at pediatric appointments. The American College of Obstetricians and Gynecologists recommends a comprehensive postpartum visit within six weeks, but only about half of women attend it. For those who do, the visit is often a single 15-minute slot that may or may not include a blood pressure reading.

The policy gap is stark: while pediatric care is structured around a schedule of frequent visits, maternal care effectively ends at discharge. A 2021 report from the CDC’s Maternal Mortality Review Committees noted that one in three pregnancy-related deaths occur between seven and 365 days postpartum, and many of these deaths are potentially preventable with timely intervention. Black women face a maternal mortality rate roughly three times that of white women, a disparity that is exacerbated by inconsistent follow-up.

Some states have attempted to close the gap. California’s Maternal Quality Care Collaborative has promoted the use of home blood pressure monitors for at-risk women, but uptake is uneven. A 2023 survey of hospitals found that only about a third routinely provide monitors at discharge. Without a systematic way to capture readings, many women fall through the cracks.

“We have a well-child system that is robust, but it doesn’t see the mother,” said Dr. Sarah Verbiest, a social work professor at the University of North Carolina who has studied postpartum care. “We need to think about the dyad, not just the infant.”

What the Data Show About Missed Diagnoses

The numbers are sobering. A 2024 analysis of US hospital discharge data estimated that nearly 50,000 women each year develop new-onset hypertension after delivery, and a substantial fraction are not diagnosed until they present to an emergency department. The CDC’s Pregnancy Mortality Surveillance System reports that cardiovascular conditions—including hypertension, cardiomyopathy, and stroke—account for about 20% of pregnancy-related deaths. Among those who survive, untreated hypertension increases the risk of stroke, heart failure, and long-term kidney damage.

The timing of these events matters. A 2023 study in JAMA Network Open found that among women with severe maternal morbidity, more than a third of readmissions occurred within 14 days of discharge—a period when many have no scheduled medical contact. Blood pressure checks at pediatric visits, which occur at 3–5 days, 2 weeks, and 1 month, could catch a significant proportion of these cases. A simulation model published in American Journal of Obstetrics & Gynecology in 2022 estimated that adding a single blood pressure screen at the 2-week well-child visit could prevent roughly 15% of postpartum hospitalizations for hypertension.

Disparities are pronounced. Black women are more likely to have preexisting hypertension and less likely to attend follow-up visits. A 2024 report from the Commonwealth Fund found that Black women were 30% less likely than white women to have a postpartum blood pressure check within 10 days of discharge. This is not simply a matter of access: the same report noted that even among women with continuous insurance, the disparity persisted, suggesting systemic biases in how care is offered.

“We have the data, we have the tools, but we don’t have the will to reorganize the workflow,” said Dr. Elizabeth Howell, a maternal-fetal medicine specialist at the University of Pennsylvania. “It’s a failure of design, not of knowledge.”

Why Baby Weight Became the Default Metric

The dominance of infant weight tracking is rooted in history and reimbursement. Pediatric growth charts, standardized by the World Health Organization and the CDC, are mandated by most state Medicaid programs and private insurers. A well-child visit generates a specific set of Current Procedural Terminology (CPT) codes, and reimbursement hinges on documenting weight, length, and head circumference. Maternal blood pressure has no corresponding code in that visit.

Clinical workflow reinforces the separation. A typical well-child appointment lasts 15 minutes. The nurse measures the baby, the doctor examines the infant, and the mother is a visitor. There is no built-in prompt for the electronic health record to remind the clinician to take the mother’s blood pressure, and no reimbursement for doing so. A 2023 survey of pediatricians found that fewer than 10% routinely check maternal blood pressure, even though three-quarters said they would be willing if it were reimbursed.

Health IT systems compound the problem. Obstetric and pediatric electronic health records are often separate, meaning a reading taken at a pediatric visit may not reach the mother’s obstetrician. A 2024 study at three academic medical centers found that only 12% of blood pressure readings taken at pediatric visits were ever communicated to the mother’s primary care or obstetric provider. “It’s like we’re two different clinics serving the same patient,” said Dr. Kelli Barbour, a maternal-fetal medicine specialist at the University of Washington.

The result is a system that incentivizes what is measured. Infant weight is easy, reimbursed, and linked to established guidelines. Maternal blood pressure is none of these. Changing this would require rethinking not just protocols but payment structures and data sharing.

Pilot Programs That Flip the Script

A handful of pilot programs are testing the idea of integrating maternal screening into pediatric visits. The University of Michigan’s “Postpartum Connect” program, launched in 2022, places a blood pressure kiosk in pediatric waiting rooms. Mothers are invited to use the kiosk before the appointment, and if the reading exceeds 140/90 mmHg, an automated alert is sent to the mother’s obstetric provider. Early data, presented at the 2024 Society for Maternal-Fetal Medicine meeting, showed that 85% of mothers agreed to be screened, and 8% were referred for further evaluation. The cost per screen was under $5.

Other programs have taken a simpler approach. At the University of California, San Francisco, nurses in the pediatric clinic are trained to ask mothers about headache and visual changes, and to take a blood pressure if symptoms are present. A 2023 report found that this low-effort intervention doubled the detection of elevated readings compared to usual care. In Colorado, a state-funded initiative provides home blood pressure monitors to all women with a diagnosis of preeclampsia, with follow-up calls from a nurse at day 3 and day 7. The program has reduced readmissions for hypertension by roughly 20%.

These pilots are small, but they demonstrate feasibility. A 2024 cost-effectiveness analysis estimated that universal blood pressure screening at pediatric visits, including the cost of the monitor and a brief counseling session, would cost about $30 per mother screened and could prevent one hospitalization for every 400 screens. For context, a single hospitalization for severe postpartum hypertension costs roughly $10,000.

“This isn’t high-tech medicine,” said Dr. Lisa Kane Low, a nurse-midwife at the University of Michigan involved in the Postpartum Connect program. “It’s a $10 cuff and a checklist. The barrier is not technology; it’s that nobody has asked the pediatric clinic to do it.”

The Practical Case for Integrated Follow-Up

Pediatric visits are frequent: the standard schedule includes five to seven well-child visits in the first year. Each is a missed opportunity for maternal screening. A simple protocol—blood pressure measurement, a depression screen (such as the PHQ-9), and contraceptive counseling—could be completed in under five minutes. A 2023 consensus statement from the American College of Obstetricians and Gynecologists and the American Academy of Pediatrics endorsed the concept of “co-located” maternal health checks at pediatric visits, but stopped short of recommending a specific mandate.

Reimbursement is the obvious hurdle. Current pediatric CPT codes do not include maternal services, and adding a new code would require action from the Centers for Medicare & Medicaid Services. Some states have begun to experiment with bundled payments: Oregon’s Medicaid program, for example, allows pediatric clinics to bill for maternal blood pressure screening under a “maternal health add-on” code. A 2024 evaluation found that clinics using the add-on screened 60% of mothers, compared to 15% in clinics without it.

Legislative momentum is building. The “Momnibus” bills, introduced in six states as of early 2025, include provisions to fund postpartum screening at pediatric visits. At the federal level, the Black Maternal Health Momnibus Act of 2025, reintroduced in Congress, includes a grant program for integrated maternal-infant care models. Whether these measures will pass is uncertain, but the conversation is shifting.

“The pediatrician sees the mother at every visit. That’s a built-in opportunity we are wasting,” said Dr. Elliott Main, medical director of the California Maternal Quality Care Collaborative. “We need to see the mother and baby as a dyad, not two separate patients.”

A System That Sees the Dyad, Not Just the Infant

Shifting from a “mother and child” to a “mother–infant dyad” model would require changes at multiple levels. The UK and the Netherlands already co-locate maternal checks: in the UK, health visitors—nurses with specialized training in maternal and child health—conduct home visits that include both infant weight and maternal blood pressure. The Netherlands’ routine postpartum care includes a midwife visit at day 3, day 7, and week 6, with blood pressure measured at each. These systems are not perfect—UK maternal mortality rates have risen in recent years—but they demonstrate that integration is possible.

In the US, maternal mortality review committees have consistently urged change. A 2024 report from the National Association of Maternal Mortality Review Committees recommended that “every postpartum encounter, including pediatric visits, should include assessment of maternal vital signs and symptoms.” The recommendation is not yet reflected in clinical guidelines, but some hospital systems are moving ahead. At the University of Texas Medical Branch, for example, the pediatric clinic now includes a “maternal health corner” with a blood pressure cuff, a depression screening tablet, and a list of community resources.

Patient advocates are pushing from the ground up. “We need a checkup too,” said Jasmine Brown, a maternal health advocate in Georgia who lost a friend to postpartum cardiomyopathy. “I had six well-baby visits in four months. Nobody once asked how I was feeling. It’s like we disappear after birth.” Her story echoes the survey data: a 2024 poll by the National Women’s Law Center found that 65% of mothers said they wished their baby’s pediatrician had asked about their own health.

None of this is to argue that infant weight tracking should be abandoned. Growth monitoring is essential for early detection of failure to thrive, obesity, and other conditions. But the current imbalance reflects a system that has not updated its priorities to match the evidence. A low-tech fix—a $10 blood pressure cuff, a checklist, and a willingness to see the mother—could save lives. Whether the US healthcare system will adopt it remains an open question.

This article is for informational purposes only and does not constitute medical advice. Readers should consult their healthcare provider for personal health decisions.